Immune and metabolic pathway proteins

Immune and metabolic pathway proteins refer to a broad and heterogeneous group of molecules involved in immunometabolism, the study of how metabolic processes regulate immune cell function and vice versa (O'Neill et al., 2016, Nature Reviews Immunology). This category encompasses enzymes, nutrient transporters, and signaling hubs that integrate environmental cues to dictate immune cell activation, differentiation, and effector functions (Buck et al., 2017, Cell). For instance, the metabolic reprogramming of T cells and macrophages is a critical determinant of their inflammatory or anti-inflammatory phenotypes (Pearce and Pearce, 2013, Immunity). Dysregulation of these pathways is a hallmark of various pathologies, including oncology, where metabolic competition in the tumor microenvironment can lead to immune exhaustion. Because this term encompasses hundreds of distinct proteins across multiple biochemical pathways, it does not constitute a single therapeutic target but rather a broad area of pharmacological interest (Ganeshan and Chawla, 2014, Annual Review of Immunology). Targeting specific nodes within these pathways offers potential for treating autoimmune diseases, chronic inflammation, and cancer by modulating the metabolic state of immune cells.

Other names

Immunometabolism proteinsMetabolic-immune regulatorsMetabolic checkpoint proteins

Not applicable as this refers to a broad class of proteins rather than a specific molecular target.